Yield10 Bioscience (YTEN.Q) Proxy Filing summary

Executive summary

• Special Meeting scheduled for November 8, 2024, to vote on four key proposals, including the sale of substantially all assets, liquidation and dissolution, adjournment authority, and a reduction in authorized shares.

• The Asset Sale involves selling nearly all operating assets to Nuseed Nutritional US Inc. for $5 million, less outstanding loans and assumed liabilities.

• If approved, the company will proceed with liquidation and dissolution, distributing remaining assets to shareholders after settling liabilities.

• The board unanimously recommends voting in favor of all proposals, citing exhausted strategic alternatives and the best interests of shareholders.

Voting matters and shareholder proposals

• Proposal 1: Approve the sale of substantially all assets to Nuseed.

• Proposal 2: Approve liquidation and dissolution following the asset sale.

• Proposal 3: Grant authority to adjourn the meeting if more time is needed to solicit votes.

• Proposal 4: Amend the certificate of incorporation to reduce authorized common shares from 150,000,000 to 2,000,000, reducing franchise tax liability.

• Board recommends voting FOR all proposals; majority of outstanding shares required for Proposals 1 and 2, majority of votes cast for Proposals 3 and 4.

Board of directors and corporate governance

• The board and management conducted extensive strategic reviews and negotiations with multiple parties over the past year.

• The board approved the asset sale and dissolution after determining no superior alternatives were available.

• Directors and executive officers may receive severance and accelerated vesting of equity awards upon termination.